Live tape
Top 8, mentions 7d6,707META2,067 mentions▲ +0.06GOOGL1,395 mentions▲ +0.02MUSE630 mentions▲ +0.07NVDA573 mentions▲ +0.08MSFT554 mentions▲ +0.06QQQ510 mentions▲ +0.08SPY492 mentions▲ +0.05TSLA486 mentions▲ +0.06

Equity · Healthcare

TFX

Teleflex Incorporated · NYSE

$134.68 −0.24% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart
Our own end-of-day closes 13 sessions
$140 $125 30 Jun 17 Jul

The line runs $127 on 30 June through $134.68 on 17 July, on a scale from $125 to $140. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of TFX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 13 sessions over that window: $127 on 30 June 2026 through $134.68 on 17 July 2026.

Market cap $5.7B
52-week range $100 – $140.91
Avg volume 113.9K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026

TFX insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 8 Sep 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 1

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
08 Sep 2026 Salmon Sean Director Award 674

TFX reported financials

SEC EDGAR XBRL

TFX reported revenue of $2.0B for the fiscal year ended 31 Dec 2025. Net income over the same period was −$905.6M.

Figure Reported Period
Revenue $2.0B 31 Dec 2025 fiscal year
Net income −$905.6M 31 Dec 2025 fiscal year
Diluted EPS −$20.25 31 Dec 2025 fiscal year
Total assets $6.8B 30 Jun 2026 at period end
Total equity $2.9B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

TFX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $2.28 $570M
31 Mar 2026 Q1 2026 $-0.18 $548M
31 Dec 2025 FY 2025 $-16.15 $569M
28 Sep 2025 FY 2025 $-9.24 $567M
29 Jun 2025 FY 2025 $2.77 $443M
30 Mar 2025 Q1 2025 $2.07 $414M

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

TFX institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a TFX position for the quarter ended 30 Jun 2026 — a combined $596.3M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Millennium Management Added +111.4% shares 1,442,103 $182.8M
Baupost Group Held (±25%) −11.7% shares 1,409,000 $178.6M
Citadel Advisors Held (±25%) −2.6% shares 1,140,950 $144.6M
Balyasny Asset Management Held (±25%) −21.5% shares 315,212 $40.0M
AQR Capital Management Added +90.6% shares 280,637 $35.2M
Renaissance Technologies Added +33.5% shares 75,700 $9.6M
Marshall Wace New position 17,106 $2.2M
D. E. Shaw & Co. Trimmed −88.5% shares 13,409 $1.7M
Man Group Added +131.4% shares 13,297 $1.7M
Point72 Asset Management Exited

Source: SEC EDGAR 13F filings

TFX fails-to-deliver

SEC CNS data

On 31 Aug 2026, 548 shares of TFX failed to deliver (about $77K).

Settlement date Shares failed Notional % of shares out
31 Aug 2026 548 $77K 0.001%
27 Aug 2026 2,018 $280K 0.005%
24 Aug 2026 546 $76K 0.001%
20 Aug 2026 961 $131K 0.002%
14 Aug 2026 6 $824 <0.001%

Source: SEC fails-to-deliver (CNS) data